Talwin

   
Google
 
Web NewDrugInformation.com

Talwin


Drug - Talwin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pentazocine Lactate
Multiple ingredients are in alphabetical order.

Strength - EQ 30MG BASE/ML
The potency of the active ingredient(s), Pentazocine Lactate. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Talwin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016194
The FDA assigned number to Talwin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Talwin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Talwin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Talwin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Talwin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Talwin.

Talwin